Phase-I Trial of Pembrolizumab and Percutaneous Cryoablation Combination Followed by Nephron-Sparing Surgery or Cytoreductive Nephrectomy in Locally Advanced and Metastatic Renal Cell Carcinomas
Clinical trial NCT03189186 · WITHDRAWN
Trial details
- NCT number
- NCT03189186
- Sponsor
- University of California, Irvine
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-01
- Primary completion
- 2018-10-17
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.